Reshma Rangwala
Chief Tech/Sci/R&D Officer bei KARYOPHARM THERAPEUTICS INC.
Vermögen: 517 826 $ am 31.03.2024
Profil
Reshma Rangwala is currently the Chief Medical Officer & Executive Vice President at Karyopharm Therapeutics, Inc. Prior to this, she held positions as the Executive Clinical Director at Merck & Co., Inc. from 2012 to 2017, Vice President-Medical at Genmab, Inc. from 2017 to 2020, and Chief Medical Officer at Aravive, Inc. from 2020 to 2022.
Dr. Rangwala completed her undergraduate degree at Duke University and obtained her doctorate from The University of Cincinnati College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.04.2024 | 342 931 ( 0,30% ) | 517 826 $ | 31.03.2024 |
Aktive Positionen von Reshma Rangwala
| Unternehmen | Position | Beginn |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01.04.2022 |
Ehemalige bekannte Positionen von Reshma Rangwala
| Unternehmen | Position | Ende |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 28.03.2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01.07.2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01.05.2017 |
Ausbildung von Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
